TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04642625

Intervention type: OTHER
Intervention: Visual Analog Score
Description: The VAS is a widely used tool in research and clinical practice, and its reliability and validity in pain assessment has been clearly demonstrated. It consists of a 100 mm line. 0 cm no pain, 10 cm is associated with 'worst possible pain'. The patient is asked to mark the line to 'score' the pain. VAS values of 1cm - 3cm weak, 4cm - 6cm moderate, and \>7cm are the indicators of severe pain.

Intervention type: OTHER
Intervention: Visual Analog Score
Description: The VAS is a widely used tool in research and clinical practice, and its reliability and validity in pain assessment has been clearly demonstrated. It consists of a 100 mm line. 0 cm no pain, 10 cm is associated with 'worst possible pain'. The patient is asked to mark the line to 'score' the pain. VAS values of 1cm - 3cm weak, 4cm - 6cm moderate, and \>7cm are the indicators of severe pain.

Intervention type: OTHER
Intervention: Visual Analog Score
Description: The VAS is a widely used tool in research and clinical practice, and its reliability and validity in pain assessment has been clearly demonstrated. It consists of a 100 mm line. 0 cm no pain, 10 cm is associated with 'worst possible pain'. The patient is asked to mark the line to 'score' the pain. VAS values of 1cm - 3cm weak, 4cm - 6cm moderate, and \>7cm are the indicators of severe pain.

Intervention type: OTHER
Intervention: patient satisfaction
Description: The patient's satisfaction with postoperative pain treatment will be recorded. 4 options; excellent, good, medium and bad.

Intervention type: OTHER
Intervention: patient satisfaction
Description: The patient's satisfaction with postoperative pain treatment will be recorded. 4 options; excellent, good, medium and bad.

Intervention type: OTHER
Intervention: patient satisfaction
Description: The patient's satisfaction with postoperative pain treatment will be recorded. 4 options; excellent, good, medium and bad.
Study: NCT05847595

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Implicit motor training program
Description: The implicit motor training aims to create a learning situation in which the learner is not (or minimally) aware of the underlying rules of the practiced motor skill. Cognitive-motor dual-task training will be used, which involves practicing hand-reaching and grasping in different locations in space while performing cognitive tasks associated with attention, memory, and executive function. The cognitive tasks include naming words, counting backwards, counting tones, counting days and months backwards, listening to a number and counting backwards by twos and threes, telling daily stories, spelling words backward, continuous subtraction of 7 from 100, and the Stroop task. The training will be tailored to the participant's abilities.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Explicit motor training program
Description: The explicit motor training aims to create a learning situation in which the learner is very aware of the learning process by providing detailed explicit instructions on each exercise. The Motion Guidance Shoulder Kit will be used for this intervention, which involves four exercises: Around the clock in flexion and abduction, Locate the Target in active range of motion, Butterfly in tracing small and large butterfly patterns, and Test your positional awareness in locating circles with eyes open and closed. The kit involves a strap around the forearm with a laser to guide the movement of the arm during the exercises.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Selected physical therapy program
Description: The selected physical therapy program, which includes shoulder joint mobilization, graduated active exercises for shoulder muscles, hand weight bearing exercises, Approximation of the upper limb joints. While, the conventional physical therapy program for the lower extremity which includes gait training, strengthening exercises and balance training .

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selected physical therapy program
Description: The selected physical therapy program, which includes shoulder joint mobilization, graduated active exercises for shoulder muscles, hand weight bearing exercises, Approximation of the upper limb joints. While, the conventional physical therapy program for the lower extremity which includes gait training, strengthening exercises and balance training .

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selected physical therapy program
Description: The selected physical therapy program, which includes shoulder joint mobilization, graduated active exercises for shoulder muscles, hand weight bearing exercises, Approximation of the upper limb joints. While, the conventional physical therapy program for the lower extremity which includes gait training, strengthening exercises and balance training .
Study: NCT06404814

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: (TENS) is a method of pain relief involving the use of a mild electrical current

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique
Description: n Spencer's technique, there are seven steps as follows: shoulder extension along with elbow flexion, shoulder flexion with elbow extension, circumduction with compression, circumduction with distraction, shoulder abduction and internal rotation with elbow flexion, shoulder adduction and external rotation with elbow
Study: NCT04889417

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive training program
Description: The COPE-iOS program is a pragmatic comprehensive training program that combines computerized cognitive training and progressive supervised video conference physical exercise sessions performed 2-4 weeks prior to surgery and for 3 months after discharge.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active control
Description: The active attention control will include control computer games and supervised video conference stretching exercises performed 2-4 weeks prior to surgery and for 3 months after discharge.
Study: NCT06460545

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sIPV (booster dose at 18 months of age)
Description: Sabin-strain-based inactivated vaccine (Vero cells), 0.5mL for each dose at 18 months of age for the booster one

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sIPV (booster dose at 18 months of age)
Description: Sabin-strain-based inactivated vaccine (Vero cells), 0.5mL for each dose at 18 months of age for the booster one

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sIPV (booster dose at 18 months of age)
Description: Sabin-strain-based inactivated vaccine (Vero cells), 0.5mL for each dose at 18 months of age for the booster one

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HepA-L
Description: Freeze-dried/lyophilized live-attenuated hepatitis A virus vaccine, 1.0mL for each dose at 18 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HepA-L
Description: Freeze-dried/lyophilized live-attenuated hepatitis A virus vaccine, 1.0mL for each dose at 18 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HepA-I
Description: Inactivated hepatitis A virus vaccine, 0.5mL for each dose, two doses at 18 and 24 months of age, respectively

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HepA-I
Description: Inactivated hepatitis A virus vaccine, 0.5mL for each dose, two doses at 18 and 24 months of age, respectively
Study: NCT06144554

Intervention type: DEVICE
Intervention: Omnipod 5
Description: The Omnipod 5 System consists of a tubeless insulin Pod and the Omnipod® 5 App, installed on a designated Controller or compatible Android smartphone. The Omnipod 5 System works with the Dexcom G6® Continuous Glucose Monitoring System to continuously adapt and automatically deliver insulin according to personal needs.~Every two weeks while on the Omnipod 5 system, participants will receive a push notification to complete assessments including any severe hypoglycemia or diabetic ketoacidosis events experienced since the prior assessment.
Study: NCT04448002

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AIM2ACT
Description: AIM2ACT is a mobile health tool that is designed to facilitate collaborative asthma management between early adolescents and their caregivers. AIM2ACT contains the following components: 1) ecological momentary assessment to identify personalized strengths and weaknesses in asthma self-management behaviors; 2) collaborative identification and tracking of goals that help early adolescents to become increasingly independent in managing their asthma; and 3) a suite of engaging skills training videos to help dyads understand how to use AIM2ACT and work together to set asthma self-management goals, develop and achieve the goals articulated in a behavioral contract, and engage in problem-solving communication.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: mHealth Attention Control Condition
Description: Dyads in the mHealth attention control condition will not receive personalized asthma management feedback, will not be guided through collaborative identification and tracking of asthma self-management goals, and will not have access to skills training videos. Instead, dyads will receive static educational information on their smartphones about behavioral management techniques they can use to target improving asthma self-management.
Study: NCT05575453

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kvatchii Portal
Description: Online education portal
Study: NCT05020028

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Description: Patients will be dispensed enough 25mg cannabidiol (CBD) Orally Disintegrating Tablets (ODT) to take a standard dose of 50mg three times daily for 84 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 25mg Placebo ODT looks like the cannabidiol (CBD) Orally Disintegrating Tablets (ODT), but contains no active ingredients.
Study: NCT04698343

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Noninvasive Peripheral Nerve Stimulation (NPNS)
Description: NPNS device programmed to deliver active stimulation.
Study: NCT06369870

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine Hydrochloride 0.25 % Injectable Solution
Description: After wound closure, the IPP-PSP block is performed at the level of the 4th rib. At the pre-axillary line, the pectoralis major, the pectoralis minor and the serratus anterior muscle are identified. At first, the needle is positioned in the fascial plane between the pectoralis minor and the serratus anterior muscle. The needle position is confirmed by hydro-dissection of this plane with 2 mL of normal saline 0.9%.The 20 ml syringe with trial drug solution is injected in this pectoserratus plane (PSP). The needle tip is repositioned in the interpectoral plane between both the pectoralis major and minor muscle. The 10 ml syringe with trial drug solution is administered in this interpectoral plane (IPP).

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sodium chloride 0.9%
Description: Unilateral (right) IPP-PSP block with 30 mL normal saline 0.9%, administered after the closure of the wounds. The IPP-PSP block procedure will be carried out as described in the intervention description of the IPP-PSP block.
Study: NCT05126563

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: HB-adMSCs (allogeneic)
Description: HB-adMSCs allogenic

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comarator
Study: NCT05219825

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathwork workshop
Description: Participants will complete 1.5 hours of breathwork session in addition to a total of 6 hours of brief psychotherapeutic intervention in a span of 1 week. The therapy sessions will occur both before and after the breathing session.
Study: NCT05371769

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chronic pain management education program
Description: The chronic pain management training program will be applied for 2 weeks. The training consists of 15 videos about theory and practice topics in chronic pain management. There are evaluation questions at the end of each video.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No intervention
Description: No intervention will be made.
Study: NCT06101043

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pectoral nerve block
Description: An ultrasound probe was placed obliquely over the second and third ribs below the lateral one-third of the clavicle. After identification of the anatomical structures, the needle was advanced along a superior-medial-to-inferior-lateral passage to the tissue plane between the pectoralis minor and serratus anterior muscles, and 20 mL ropivacaine (0.375% w/v) was injected at the level of the third rib. The anesthetic spread around the axilla, and the needle was withdrawn to the point in the plane between the pectoralis major and minor muscles. A second injection of 20 mL ropivacaine (0.375% w/v) was then delivered (PECS II).
Study: NCT04725240

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Setmelanotide
Description: Setmelanotide for SC injection
Study: NCT06560385

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: BLHK03
Description: BLHK03 consists of a blend of probiotics (20 billion CFU in 1 sachet) and prebiotic compounds

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Active placebo
Description: Active placebo contains 5mcg of Vitamin B7
Study: NCT05375669

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ISIS IOM System
Description: The constant-current TES stimulators will be used in this study with a high-precision oscilloscope. The calibration will assess 5-pulse trains with a 4 ms ISI and 100 mA output across a 1000 Ω resistor at 250, 500, and 1000 µs D. Measurements will include actual I and D of each pulse, and actual ISI.~Total intravenous anesthesia (TIVA), surgery and TES MEP monitoring will proceed routinely without modification and normally involves acquiring many MEPs over several hours. The only departure from standard care will be the placement of two small accelerometers and a brief MEP sequence before skin incision to determine chronaxie and compare the effect of an equivalent increase of I or D on MEP amplitude and movement.
Study: NCT04421950

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Wild blueberry containing foods
Description: Foods that contain wild blueberry supplement to deliver up to 30 grams of blueberry powder

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo containing foods
Description: Foods that do not contain the blueberry powder but a placebo
Study: NCT06067516

Intervention type: OTHER
Intervention: Fluid resuscitations
Description: In line with the recommendations in the Surviving Sepsis Guide, fingertip capillary refill time (CRT) will be measured by applying pressure to the index finger for 15 seconds in the T1 time period after 30 mL/kg/3 hours crystalloid infusion.

Intervention type: OTHER
Intervention: Fluid resuscitations
Description: In line with the recommendations in the Surviving Sepsis Guide, fingertip capillary refill time (CRT) will be measured by applying pressure to the index finger for 15 seconds in the T1 time period after 30 mL/kg/3 hours crystalloid infusion.
Study: NCT04657679

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ribociclib
Description: Patients will receive ribociclib 600 mg oral (PO) daily for 21 consecutive days of 28-day cycles and endocrine therapy with either letrozole or fulvestrant. Fulvestrant 500 mg intramuscular (IM) will be administered on days 1, 15, 29 of cycle one, and then monthly. Letrozole 2.5 mg oral daily continuously. If premenopausal women have not undergone bilateral salpingo- oophorectomy, they will receive a luteinizing hormone-releasing hormone (LHRH) agonist (e.g., goserelin leuprolide) for ovarian suppression in combination with fulvestrant or letrozole and ribociclib.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ribociclib
Description: Patients will receive ribociclib 600 mg oral (PO) daily for 21 consecutive days of 28-day cycles and endocrine therapy with either letrozole or fulvestrant. Fulvestrant 500 mg intramuscular (IM) will be administered on days 1, 15, 29 of cycle one, and then monthly. Letrozole 2.5 mg oral daily continuously. If premenopausal women have not undergone bilateral salpingo- oophorectomy, they will receive a luteinizing hormone-releasing hormone (LHRH) agonist (e.g., goserelin leuprolide) for ovarian suppression in combination with fulvestrant or letrozole and ribociclib.
Study: NCT06151405

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DGA Diet
Description: A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans (DGA)~Including:~* A variety of vegetables and fruits~* Grains, at least half of which are whole grains~* Fat-free or low-fat dairy~* A variety of protein foods, including seafood, lean meats and poultry, eggs, legumes, nuts, and seeds~* This healthy eating pattern also limits saturated fats and trans fats, added sugars, and sodium.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MCT Diet
Description: A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KETO Diet
Description: A fully provisioned isocaloric, isonitrogenous ketogenic study diet.
Study: NCT05543603

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacer Clorhexidina Colutorio
Description: 15 ml 0,12% Chlorhexidine, one minute rinse

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacer Clorhexidine 0.20% Colutorio
Description: 15 ml 0,2% Chlorhexidine, one minute rinse

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gingilacer Encías Delicadas Colutorio
Description: 15 ml 0,10% cymenol + 0,10% zinc chloride, one minute rinse

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Distilled water
Description: 15 ml distilled water, one minute rinse
Study: NCT04453657

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FamilyChildCare (provisional name of app)
Description: Parents will provide their child(ren) access to a smartphone, tablet, or computer for approximately 30 minutes, three times per week for 15 weeks with a total dosage of instruction of about 22.5 hours. Parents and providers will receive self-care, parenting, and parent engagement tips and resources through push notifications twice a day. Additionally, daily reminders will be sent to parents through push notification to give their child(ren) access to the learning games. After 15 weeks of app engagement, the providers and parents will be contacted by the PI to notify them of the 15 week time mark and provide the information for post-surveys via Qualtrics.
Study: NCT05699187

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Face allotransplantation
Description: Facial allotransplantation
Study: NCT05426928

Intervention type: OTHER
Intervention: Additional temperature monitoring/recording
Description: All patients in this study will receive the same standard of care treatment for their HIPEC procedure. The only difference will be the use of additional temperature probes to collect more robust data regarding intraabdominal temperature, and the prospective collection of actual boundary conditions of the system.
Study: NCT04307771

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: m-Health application
Description: Dental Buddy is a mobile application that has been designed to improve oral hygiene maintenance behaviours in teenagers

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: m-Health application
Description: Dental Buddy is a mobile application that has been designed to improve oral hygiene maintenance behaviours in teenagers
Study: NCT06234878

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: REEV SENSE
Description: Gait analysis with an Inertial Measurement Unit (IMU) sensor

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Motion capture system
Description: Gait analysis with reflective markers and pressure sensors
Study: NCT05420506

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NROT1
Description: Dental anchored intestinal placement of obesity treatment device with endoscopic intervention
Study: NCT05927285

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Vexus
Description: The VExUS group was considered the intervention group, where in addition to all the above, the decision for decongestant treatment was guided by the VExUS score until reaching a score that VExUS considered noncongestive, which was grade 0.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: The control group is considered the conventional approach, where the treatment was guided by improvement in clinical data, imaging, or laboratory studies during the daily evaluation until categorized as decongested
Study: NCT05493891

Intervention type: OTHER
Intervention: Visual analogue scale (VAS)
Description: VAS is a reliable and valid method for assessing the intensity of low back pain (LBP)

Intervention type: OTHER
Intervention: Visual analogue scale (VAS)
Description: VAS is a reliable and valid method for assessing the intensity of low back pain (LBP)

Intervention type: OTHER
Intervention: Visual analogue scale (VAS)
Description: VAS is a reliable and valid method for assessing the intensity of low back pain (LBP)

Intervention type: DEVICE
Intervention: Pressure Biofeedback Unit (PBU)
Description: PBU is a valid and reliable instrument for measuring the maximal voluntary isometric contraction of both lumbar multifidus and transversus abdominis muscles (core muscle strength)

Intervention type: DEVICE
Intervention: Pressure Biofeedback Unit (PBU)
Description: PBU is a valid and reliable instrument for measuring the maximal voluntary isometric contraction of both lumbar multifidus and transversus abdominis muscles (core muscle strength)

Intervention type: DEVICE
Intervention: Pressure Biofeedback Unit (PBU)
Description: PBU is a valid and reliable instrument for measuring the maximal voluntary isometric contraction of both lumbar multifidus and transversus abdominis muscles (core muscle strength)
Study: NCT05027321

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preparation in Self-Hypnosis by anchoring
Description: Preparation in Self-Hypnosis by anchoring just before examination

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conversational Hypnosis
Description: Conversational Hypnosis during examination

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preparation in Self-Hypnosis by anchoring + Conversational Hypnosis
Description: Preparation in Self-Hypnosis by anchoring just before examination combied with Conversational Hypnosis during examination